-
Mashup Score: 3Pharmas form joint venture to jumpstart Japanese drug research - 25 day(s) ago
A new initiative backed by Takeda, Astellas and Sumitomo Mitsui Banking aims to combat a decade-long decline in drug R&D productivity in Japan.
Source: www.biopharmadive.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 200
The personalized therapy uses a patient’s own immune cells to recognize and fight cancer
Source: endeavor.moffitt.orgCategories: General Medicine News, Future of MedicineTweet-
.@US_FDA approves breakthrough tumor-infiltrating lymphocyte (TIL) therapy for metastatic melanoma #NBTNewsBeat https://t.co/mRGJj2BSj2
-
-
Mashup Score: 199
The personalized therapy uses a patient’s own immune cells to recognize and fight cancer
Source: endeavor.moffitt.orgCategories: General Medicine News, Future of MedicineTweet-
.@US_FDA approves breakthrough tumor-infiltrating lymphocyte (TIL) therapy for metastatic melanoma #NBTNewsBeat https://t.co/mRGJj2BSj2
-
-
Mashup Score: 190
The personalized therapy uses a patient’s own immune cells to recognize and fight cancer
Source: endeavor.moffitt.orgCategories: General Medicine News, Future of MedicineTweet-
.@US_FDA approves breakthrough tumor-infiltrating lymphocyte (TIL) therapy for metastatic melanoma #NBTNewsBeat https://t.co/mRGJj2BSj2
-
-
Mashup Score: 302
The landmark decision could transform the treatment of sickle-cell disease and β-thalassaemia — but the technology is expensive.
Source: www.nature.comCategories: General Medicine News, Future of MedicineTweet-
The UK medicines regulator approves the first therapy using CRISPR gene editing. @VertexPharma and @CRISPRTX's Casgevy will treat the blood conditions sickle-cell disease and β-thalassemia #NBTNewsBeat https://t.co/sqHXP1byNT
-
-
Mashup Score: 302
The landmark decision could transform the treatment of sickle-cell disease and β-thalassaemia — but the technology is expensive.
Source: www.nature.comCategories: General Medicine News, Future of MedicineTweet-
The UK medicines regulator approves the first therapy using CRISPR gene editing. @VertexPharma and @CRISPRTX's Casgevy will treat the blood conditions sickle-cell disease and β-thalassemia #NBTNewsBeat https://t.co/sqHXP1byNT
-
-
Mashup Score: 8New Gene Editing Treatment Cuts Dangerous Cholesterol in Small Study (Gift Article) - 6 month(s) ago
The trial involved only 10 patients, but it suggests cholesterol can be permanently reduced with a single treatment for patients at risk of heart disease.
Source: www.nytimes.comCategories: General Medicine News, Future of MedicineTweet-
New gene editing treatment cuts dangerous cholesterol in small study #NBTNewsBeat https://t.co/cDZss2D3Xs
-
-
Mashup Score: 7EU seeks to relax gene-edited crop restrictions - 11 month(s) ago
The European Commission proposed revising its rules on genetically modified organisms (GMOs) on Wednesday to loosen some restrictions for plants resulting from newer gene-editing technology.
Source: ReutersCategories: Future of Medicine, Latest HeadlinesTweet-
The EU proposes revising its rules on GMOs to loosen some restrictions for plants resulting from gene-editing technology to give farmers more resilient crops, reduce pesticide use and offer consumers food with higher nutritional value #NBTNewsBeat https://t.co/o3qzNuFp7R
-
-
Mashup Score: 2USDA Approves ‘Lab-Grown’ Chicken—Here’s Where To Buy It - 11 month(s) ago
Customers wanting lab-grown meat will have to venture to upscale restaurants in San Francisco or D.C. for now, according to the Associated Press, since It’ll likely take years before cultivated chicken reaches American grocery carts because of the need to ramp up production capabilities.
Source: ForbesCategories: Future of Medicine, Latest HeadlinesTweet-
The @USDA approves the sale of chicken made from animal cells, allowing two companies, @GOODMeat and @upsidefoods, to bring “lab-grown” meat to restaurants in Washington and San Francisco #NBTNewsBeat via @forbes https://t.co/4j0BgIFZjd
-
-
Mashup Score: 2Theranos founder Elizabeth Holmes begins 11-year prison sentence - 12 month(s) ago
Holmes arrived at a federal prison in Texas on Tuesday, according to a prison spokesman.
Source: Yahoo FinanceCategories: Future of Medicine, Latest HeadlinesTweet-
Theranos founder Elizabeth Holmes begins serving an 11-year prison sentence, completing a dramatic fall for the biotech entrepreneur who once dazzled Silicon Valley with promises of breakthrough blood-testing technology #NBTNewsBeat https://t.co/KrNJYqUVMF
-
Pharmas form joint venture to jumpstart Japanese drug research #NBTNewsBeat via @BioPharmaDive https://t.co/Yu0PKWXjsd